Molecular mechanism of corneal epithelial stratification and innervation
Molecular mechanism of corneal epithelial stratification and innervation
批准号:
10855640
负责人:
CHIA-YANG LIU
金额:
$45.15万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-04-01 至 2024-03-31
中文摘要
项目总结/摘要
角膜上皮(CE)由单层基底细胞和4-5层非基底细胞组成,
角化的、复层的鳞状上皮细胞,以形成有效的屏障防止液体流失,
病原体CE主要由密度极高的三叉神经感觉传入神经支配,
它提供了对环境损害的巨大敏感性,
通过调节眨眼反应和刺激流泪来保护眼组织免受损伤。任何
CE分层和神经支配的破坏可能对脑组织的完整性产生有害影响。
导致神经营养性角膜病和角膜盲。关于这一点,我们知之甚少。
分子和细胞机制,CE分层和神经支配的实现,
角膜形态发生并持续到成年期。在本提案中,我们试图
探讨Shp 2介导的Ras丝裂原活化蛋白激酶(Ras-MAPK)通路,
它对细胞的各种活动和行为极其重要,但尚未被研究
CE分层和神经支配。我们假设Shp 2介导的MAPK信号通路
通过调节HCNp 63的表达来控制CE分层和神经支配。三个目标是
提议:
目的:1.阐明Shp 2 →Ras→Mek→E-cadherin →E-cadherin信号通路在肝癌细胞凋亡中的作用。
发育过程中和发育后的角膜上皮分层。
目的2:阐明CE的Shp 2 →Ras→Mek→ JNp 63 →NGF信号轴在细胞凋亡中的作用。
CNV 1在发育期间和之后的神经支配。
目的3是通过过度表达
Shp 2cko小鼠中的Np 63 α。
完成拟定目标将描述与Shp 2介导的
Ras-MAPK途径微调JNP 63,进而调节E-钙粘蛋白和NGF,
在角膜发育和维持过程中CE的分层和神经支配
体内平衡这些知识有很大的潜力,导致发现基于路径的
分子靶点治疗角膜疾病,如神经营养性角膜病变。
英文摘要
PROJECT SUMMARY/ABSTRACT
Corneal epithelium (CE) is composed of a single layer of basal cells and 4-5 cell layers of non-
keratinized, stratified squamous epithelial cells to form an effective barrier against fluid loss and
pathogen. CE is mainly innervated by trigeminal sensory afferents with extremely high density,
which offers enormous sensitivity to the environmental insults for protecting otherwise deeper
ocular tissues from damage by modulating the blink response and stimulating lacrimation. Any
disruption of CE stratification and innervation can have deleterious effects on the integrity of the
cornea and lead to neurotrophic keratopathy and corneal blindness. Little is known regarding the
molecular and cellular mechanisms by which CE stratification and innervation is achieved during
corneal morphogenesis and continuously sustained in the adulthood. In this proposal, we attempt
to explore Shp2-mediated Ras–mitogen-activated protein kinase (Ras-MAPK) pathway which is
extremely important for wide variety of cellular activities and behaviors, but it has not been studied
in the CE stratification and innervation. We hypothesize that Shp2-mediated MAPK signaling
controls CE stratification and innervation via regulating ∆Np63 expression. Three aims are
proposed:
Aim 1 is to elucidate the role of Shp2→Ras→Mek→∆Np63→E-cadherin signaling pathway in
corneal epithelial stratification during and following development.
Aim 2 is to elucidate the role of Shp2→Ras→Mek→∆Np63→NGF signaling axis of the CE on the
CNV1 innervations during and following development.
Aim 3 is to rescue otherwise impaired CE stratification and innervation by overexpression of
∆Np63α in Shp2cko mice.
Completion of proposed objectives will delineate mechanistic event related to the Shp2-mediated
Ras-MAPK pathway to fine-tune ∆Np63, which in turn regulate E-cadherin and NGF, to faciliate
stratification and innervation of CE during development and in the maintenance of corneal
homeostasis. This knowledge has great potential to lead to the discovery of pathway-based
molecular target to treat corneal diseases such as neurotrophic keratopathy.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Role of Tgf-beta-signaling in corneal development and diseases
-
批准号:10254192
-
项目类别:
-
资助金额:$9.01万
-
财政年份:2020
-
负责人:CHIA-YANG LIU
-
依托单位:
Molecular mechanism of corneal epithelial stratification and innervation
-
批准号:10376207
-
项目类别:
-
资助金额:$6.36万
-
财政年份:2019
-
负责人:CHIA-YANG LIU
-
依托单位:
Molecular mechanism of corneal epithelial stratification and innervation
-
批准号:9902497
-
项目类别:
-
资助金额:$53.1万
-
财政年份:2019
-
负责人:CHIA-YANG LIU
-
依托单位:
New Insights into the Ocular Surface in Health and Disease
-
批准号:9330185
-
项目类别:
-
资助金额:$42.01万
-
财政年份:2015
-
负责人:CHIA-YANG LIU
-
依托单位:
New Insights into the Ocular Surface in Health and Disease
-
批准号:9135400
-
项目类别:
-
资助金额:$42.58万
-
财政年份:2015
-
负责人:CHIA-YANG LIU
-
依托单位:
New Insights into the Ocular Surface in Health and Disease
-
批准号:8887413
-
项目类别:
-
资助金额:$42.41万
-
财政年份:2015
-
负责人:CHIA-YANG LIU
-
依托单位:
Mouse Model for Eyelid Disease: Congenital Blepharophimosis
-
批准号:9109760
-
项目类别:
-
资助金额:$38.22万
-
财政年份:2015
-
负责人:CHIA-YANG LIU
-
依托单位:
Mouse model for eyelid disease: Congenital blepharophimosis
-
批准号:8323433
-
项目类别:
-
资助金额:$39.25万
-
财政年份:2011
-
负责人:CHIA-YANG LIU
-
依托单位:
Mouse model for eyelid disease: Congenital blepharophimosis
-
批准号:8531945
-
项目类别:
-
资助金额:$37.29万
-
财政年份:2011
-
负责人:CHIA-YANG LIU
-
依托单位:
In vivo model for ocular surface disorder: Congenital Blepharophimosis
-
批准号:8722563
-
项目类别:
-
资助金额:$38.47万
-
财政年份:2011
-
负责人:CHIA-YANG LIU
-
依托单位:
Mouse model for eyelid disease: Congenital blepharophimosis
-
批准号:8085434
-
项目类别:
-
资助金额:$39.25万
-
财政年份:2011
-
负责人:CHIA-YANG LIU
-
依托单位:
ROLE OF KERATOCAN IN CORNEAL BIOLOGY
-
批准号:7383279
-
项目类别:
-
资助金额:$39.25万
-
财政年份:2001
-
负责人:CHIA-YANG LIU
-
依托单位:
THE ROLE OF KERATOCAN IN CORNEAL BIOLOGY
-
批准号:7180623
-
项目类别:
-
资助金额:$26.86万
-
财政年份:2001
-
负责人:CHIA-YANG LIU
-
依托单位:
THE ROLE OF KERATOCAN IN CORNEAL BIOLOGY
-
批准号:6710059
-
项目类别:
-
资助金额:$26.51万
-
财政年份:2001
-
负责人:CHIA-YANG LIU
-
依托单位:
THE ROLE OF KERATOCAN IN CORNEAL BIOLOGY
-
批准号:6688228
-
项目类别:
-
资助金额:$26.51万
-
财政年份:2001
-
负责人:CHIA-YANG LIU
-
依托单位:
THE ROLE OF KERATOCAN IN CORNEAL BIOLOGY
-
批准号:6196189
-
项目类别:
-
资助金额:$25.77万
-
财政年份:2001
-
负责人:CHIA-YANG LIU
-
依托单位:
THE ROLE OF KERATOCAN IN CORNEAL BIOLOGY
-
批准号:6498333
-
项目类别:
-
资助金额:$9.73万
-
财政年份:2001
-
负责人:CHIA-YANG LIU
-
依托单位:
THE ROLE OF KERATOCAN IN CORNEAL BIOLOGY
-
批准号:6628652
-
项目类别:
-
资助金额:$16.8万
-
财政年份:2001
-
负责人:CHIA-YANG LIU
-
依托单位:
国内基金
海外基金
登录
查看更多内容
糖尿病ED中成纤维细胞衰老调控内皮细胞线粒体稳态失衡的机制研究
-
批准号:82371634
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:赵福军
-
依托单位:
PRNP调控巨噬细胞M2极化并减弱吞噬功能促进子宫内膜异位症进展的机制研究
-
批准号:82371651
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:赵栋
-
依托单位:
CBP/p300-HADH轴在基础胰岛素分泌调节中的作用和机制研究
-
批准号:82370798
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:王晓
-
依托单位:
生物钟核受体Rev-erbα在缺血性卒中神经元能量代谢中的改善作用及机制研究
-
批准号:82371332
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:胡琴
-
依托单位:
TIPE2调控巨噬细胞M2极化改善睑板腺功能障碍的作用机制研究
-
批准号:82371028
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:赵慧
-
依托单位:
慢性炎症诱发骨丢失的机制及外泌体靶向治疗策略研究
-
批准号:82370889
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:傅德皓
-
依托单位:
配子生成素GGN不同位点突变损伤分子伴侣BIP及HSP90B1功能导致精子形成障碍的发病机理
-
批准号:82371616
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:姚晨成
-
依托单位:
超声驱动压电效应激活门控离子通道促眼眶膜内成骨的作用及机制研究
-
批准号:82371103
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:阮静
-
依托单位:
5'-tRF-GlyGCC通过SRSF1调控RNA可变剪切促三阴性乳腺癌作用机制及干预策略
-
批准号:82372743
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:陈卓佳
-
依托单位:
骨髓ISG+NAMPT+中性粒细胞介导抗磷脂综合征B细胞异常活化的机制研究
-
批准号:82371799
-
项目类别:面上项目
-
资助金额:47.00万元
-
批准年份:2023
-
负责人:杨程德
-
依托单位: